News and Community

Act-101, Aptar, Aso Therapy, Cystic Fibrosis Therapy, Healthcare Technology, Inhaled Biologics, Nanopharm, Nucleic Acid Therapeutics, Rna Therapeutics

September 8, 2026

Aptar, Aceso Therapeutics Announce Collaboration to Develop Inhaled Antisense Oligonucleotide Therapy for Cystic Fibrosis